These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24993350)

  • 1. Use of misoprostol for self-induced medical abortions among Saudi women: a call for attention.
    Alsibiani SA
    Gynecol Obstet Invest; 2014; 78(2):88-93. PubMed ID: 24993350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The knowledge, acceptability, and use of misoprostol for self-induced medical abortion in an urban US population.
    Rosing MA; Archbald CD
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):183-5. PubMed ID: 10846334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, attitudes and knowledge of misoprostol for self-induction of abortion in women presenting for abortion at Midwestern reproductive health clinics.
    Kerestes C; Sheets K; Stockdale CK; Hardy-Fairbanks AJ
    Sex Reprod Health Matters; 2019 Dec; 27(1):1571311. PubMed ID: 31533561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion.
    Kopp Kallner H; Fiala C; Gemzell-Danielsson K
    Contraception; 2012 Apr; 85(4):394-7. PubMed ID: 22067756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe morbidities associated with induced abortions among misoprostol users and non-users in a tertiary public hospital in Ghana.
    Damalie FJ; Dassah ET; Morhe ES; Nakua EK; Tagbor HK; Opare-Addo HS
    BMC Womens Health; 2014 Jul; 14():90. PubMed ID: 25074294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: a 10-year-experience.
    Pongsatha S; Tongsong T
    J Med Assoc Thai; 2011 Aug; 94(8):897-901. PubMed ID: 21863669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical abortion using methotrexate and misoprostol. Efficacy and tolerability].
    Iamakov K; Pekhlivanov B; Amaliev I
    Akush Ginekol (Sofiia); 2005; 44(3):16-8. PubMed ID: 16028385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol.
    Vitner D; Deutsch M; Paz Y; Khatib N; Baltiter T; Rosenberg S; Lowenstein L
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):140-3. PubMed ID: 21507550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
    Bracken H; Dabash R; Tsertsvadze G; Posohova S; Shah M; Hajri S; Mundle S; Chelli H; Zeramdini D; Tsereteli T; Platais I; Winikoff B
    Contraception; 2014 Mar; 89(3):181-6. PubMed ID: 24332431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose misoprostol as an alternative therapy after failed medical abortion.
    Li YT; Hou GQ; Chen TH; Chu YC; Lin TC; Kuan LC; Lin M; Huang SF; Chen FM; Kuo TC
    Taiwan J Obstet Gynecol; 2008 Dec; 47(4):408-11. PubMed ID: 19126506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial.
    Chaudhuri S; Banerjee PK; Mundle M; Mitra SN
    Trop Doct; 2010 Jul; 40(3):144-8. PubMed ID: 20555044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion.
    Ellis SC; Kapp N; Vragpvoc O; Borgata L
    Contraception; 2010 May; 81(5):441-5. PubMed ID: 20399952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions.
    Aldrich T; Winikoff B
    BJOG; 2007 May; 114(5):555-62. PubMed ID: 17439563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
    Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of misoprostol for pregnancy termination in women with prior classical cesarean delivery: a report of 3 cases.
    Malapati R; Villaluna G; Nguyen TM
    J Reprod Med; 2011; 56(1-2):85-6. PubMed ID: 21366135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate. A single agent for early abortion.
    Schaff EA; Penmetsa U; Eisinger SH; Franks P
    J Reprod Med; 1997 Jan; 42(1):56-60. PubMed ID: 9018647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of home-use of misoprostol in medical abortion.
    Fiala C; Winikoff B; Helström L; Hellborg M; Gemzell-Danielsson K
    Contraception; 2004 Nov; 70(5):387-92. PubMed ID: 15504378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.